Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi(Centre National de la Recherche Scientifique), Hervé Ghesquières(Hôpital Lyon Sud)

American Journal of Hematology

June 9, 2018

10.1002/ajh.25154

Cited by 120

Related Papers

A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

|BMC Public Health|2021|17